N
LLY icon

Natixis’s Eli Lilly LLY Stock Holding History

Natixis’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed -$2K – 1240
2022
Q3 		$2K Sell
7
-5
-42% -$1.58K ﹤0.01% 1046
2022
Q2 		$4K Buy
+12
New +$3.6K ﹤0.01% 1102

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Natixis's LLY Position: Q1 2026 in Review

Natixis reduced its Eli Lilly (LLY) stake by 51% in Q1 2026, selling an estimated $105M and leaving 100,947 shares worth $92.8M. The position accounts for 0.33% of the portfolio, ranked #41.

Natixis first reported a position in LLY in Q2 2013 and has held it in 44 quarters since. The position peaked at $267M in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Natixis held 100,947 shares of Eli Lilly worth $92.8M as of Q1 2026.
  • Natixis sold 104,055 Eli Lilly shares in Q1 2026, an estimated $105M.
  • Eli Lilly made up 0.33% of Natixis's portfolio in Q1 2026, its #41 holding.
  • Natixis first reported a position in Eli Lilly in Q2 2013 and has held it in 44 quarters since.
  • Natixis's Eli Lilly position peaked at $267M in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.